Feature Reviews in Cancer Therapy
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: closed (15 December 2022) | Viewed by 42930
Special Issue Editor
Interests: cancer cell pharmacology; anticancer drugs; drug resistance; predictive biomarkers; DNA damage response; cell signaling; tumor microenvironment
Special Issue Information
Dear Colleagues,
We are pleased to announce the launch of a new Special Issue entitled "Feature Reviews in Cancer Therapy". This is a collection of important high-quality review papers related to all aspects of cancer therapy: chemotherapy, immunotherapy, combination therapy, target discovery, precision medicine, systems medicine, dynamic risk and relapse assessment, etc., published in open access form. This collection aims to discuss new knowledge or new cutting-edge developments in cancer therapy through selected works, which will make a great contribution to the community.
We welcome warmly all colleagues active in this field to contribute. Additionally, we also encourage authors to send their abstracts for pre-evaluation to avoid overlaps in the reviewed subjects. Please note that selected full papers will still be subjected to a thorough and rigorous peer review.
Prof. Dr. Alexandre Escargueil
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.